In addition, plasma AmiR-27a and miR-218 together with miR-21 were also verified to have significantly higher expression and potential for indicating primary resistance to EGFR-TKIs in advanced NSCLC patients with EGFR exon 19 deletion mutations [156]. Here, EGFR is linked to non-small cell lung carcinoma.